US lawmakers are demanding answers from the Food and Drug Administration about a shortage of infant formula products as demand for production by other firms grows following the closing of an Abbott Nutrition plant due to contamination concerns.
House Appropriations and Energy and Commerce subcommittee members also will ask about the recall by the Abbott Laboratories Ltd
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?